Related by context. Frequent words. (Click for all words.) 74 multi kinase inhibitor 70 Panzem R 70 Factor VIIa 69 luteinizing hormone releasing 68 Vandetanib 68 pertuzumab 68 PEG SN# 68 forodesine 67 GLPG# 67 Mipomersen 67 advanced carcinoid 67 Aliskiren 67 Cetrorelix 67 Epratuzumab 67 elotuzumab 67 KRN# 67 Pivotal Phase III 67 Aurora kinase 67 proteasome inhibitor 67 nicotinic alpha 7 67 Zolinza 67 gastrointestinal stromal tumors GIST 66 MEK inhibitor 66 Initiate Phase 66 Sym# 66 phase IIb clinical 66 orally bioavailable 66 PARP inhibitor 66 R sorafenib tablets 66 vorinostat 66 CYC# 66 Dasatinib 66 Bortezomib 66 Ixempra 66 CR# vcMMAE 66 ganetespib 66 Azedra 66 Irinotecan 66 TLR9 agonist 66 EZN 66 Metastatic Melanoma 66 liposomal formulation 66 mTOR inhibitor 66 deforolimus 66 Elesclomol 66 angiogenesis inhibitor 65 myeloproliferative disorders 65 HGS ETR1 65 IMC #B 65 relapsed multiple myeloma 65 Eltrombopag 65 L Annamycin 65 metastatic hormone refractory 65 humanized antibody 65 IMC A# 65 ATL# [001] 65 hypoxia inducible factor 65 multiple myeloma MM 65 HER2 positive metastatic breast 65 novel orally administered 65 relapsed refractory multiple myeloma 65 HCV protease inhibitor 65 Voreloxin 65 Amrubicin 65 JAK3 64 ISTODAX 64 Nexavar ® 64 humanized anti 64 ixabepilone 64 enzastaurin 64 cutaneous T cell 64 Carfilzomib 64 enzyme inhibitor 64 CA4P 64 Phase III Clinical Trial 64 Ofatumumab 64 BAY #-# 64 partial agonist 64 OncoMed 64 BZL# 64 Presents Positive 64 SAR# [004] 64 INCB# [001] 64 Tesetaxel 64 Monoclonal Antibody 64 Boceprevir 64 humanized monoclonal antibody 64 otelixizumab 64 thymalfasin 64 Herceptin trastuzumab 64 Gefitinib 64 Rebif ® 64 II Clinical Trial 64 anti mitotic 64 teplizumab 64 MGCD# [001] 64 Cloretazine R VNP#M 64 OncoVEX GM CSF 64 Drug Candidate 64 GGF2 64 Patient Enrollment